Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FB1L5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,666
Award facts
- Contract value 100% obligated
- $25,665.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 8, 2026, for Ibrance 125 mg tablets (7-count units) with a ceiling value of $25,665.63 under a firm fixed-price arrangement.
Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 29, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FB1L5?
SPE2DR26FB1L5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 8, 2026.
How much is contract SPE2DR26FB1L5 worth?
The government has obligated $25,666 on SPE2DR26FB1L5.
Is contract SPE2DR26FB1L5 an order under another contract?
Yes. SPE2DR26FB1L5 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FB1L5 competed?
The extent of competition for SPE2DR26FB1L5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award